id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1247-0006,FDA,FDA-2012-E-1247,Determination of Regulatory Review Period for Purposes of Patent Extension; BELVIQ,Other,Letter(s),2017-03-10T05:00:00Z,2017,3,2017-03-10T05:00:00Z,,2017-03-10T16:45:50Z,,0,0,090000648250021c